KDIGO's new IgA nephropathy guideline shifts the treatment paradigm from supportive care alone to targeting the disease's immunologic nature.

Early diagnosis and intervention create a return on investment model where up-front costs for screening, diagnosis, and early treatment yield substantial downstream cost savings while simultaneously ...

After the diagnosis of micro- or macroalbuminuria is confirmed, patients should undergo a complete evaluation, including a work-up for other etiologies and an assessment of renal function and the ...

Medically reviewed by David Ozeri, MD IgA nephropathy mainly affects the kidneys, while IgA vasculitis can also involve your skin, joints, and digestive system.IgA vasculitis often appears suddenly ...

Panelists discuss how immunoglobulin A (IgA) nephropathy diagnosis requires kidney biopsy with immunofluorescence showing dominant or codominant IgA deposits in the mesangium, often accompanied by C3 ...

IgA nephropathy has a complex hereditary pattern. You may not develop it unless you inherit multiple risk genes and also ...

GFR is key marker of kidney function; IgAN is progressive autoimmune kidney disease that leads to kidney failure in many patients 1-3 Fabhalta is first and only approved complement inhibitor for ...

Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...

This study was partially supported by Projeto de Núcleos de Excelência do Ministério de Ciência e Tecnologia, Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Hospital de ...

Novartis Fabhalta meets phase III primary endpoint, slows kidney function decline in patients with IgA nephropathy: Basel Friday, October 17, 2025, 10:00 Hrs [IST] Novartis announ ...